IPO Premiums
IPO calendar
RSListed

Royal Sense Limited

Fixed Price Issue IPO · BSE

Price band
₹68 - ₹68
Lot size
2,000 shares
Issue amount
₹9.86 cr
Total subscription
8.65×
Current price₹74
Listing price ₹129.2
Watch live price ↗
Opens
12 Mar 2024
Closes
14 Mar 2024
Allotment
15 Mar 2024
Listing
19 Mar 2024

Offer at a glance

Issue overview

Issue size
14,50,000 shares
Face value
₹10 Per Equity Share
Minimum investment
₹1,36,000
Fresh issue
₹9.86 cr
Offer for sale
₹0 cr
Registrar
Bigshare Services Private Limited
Listing exchange
BSE
Maximum investment
₹1,36,000
Issue type
Fixed Price Issue IPO
Shares before issue
34,50,146
Shares after issue
49,00,146

Lot sizes

CategoryLotsSharesAmount
RETAIL12,000₹1,36,000
HNI24,000₹2,72,000

Share reservation

RETAIL44.5%
NII (HNI) 44.4%
Market Maker 11.03%

Subscription & GMP

Subscription by category

Total subscribed8.65×

Missing multiples are calculated from bids and offered shares when available.

NIB9.99×
RETAIL7.31×

GMP history

018.53712 Mar: ₹3719 Nov: ₹37
12 Mar₹3719 Nov

Application-wise demand

CategoryReserved applicationsApplied applications
——

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
RETAIL4.3932.1
NIB4.3843.75

Financial performance

Company financials

in ₹ Lakhs · Reported periods may include interim results.

Revenue & profitin ₹ Lakhs
05001,000Sep-23 · Revenue: 804.07Sep-23 · Profit after tax: 70.28Sep-23
RevenueProfit after tax

Key performance indicators

MetricValues
EPS2.04
ROE17
ROCE23
RONW17
PRE IPO(PE)2.04
POST IPO(PE)0

Values and labels as reported in the issue data.

Company information

Company profile

Royal Sense Limited, established in 2023, is a dedicated provider of medical equipment, surgical instruments, consumables, laboratory essentials, and diagnostic kits. Originally operating under the proprietorship of Mr. Rishabh Arora as "M/s Royal Traders, PHT and Anaya," the company transitioned into its current structure following its acquisition on April 28, 2023. Catering to the Ministry of Health Departments in Uttar Pradesh, Himachal Pradesh, Rajasthan, and Jammu & Kashmir, as well as government institutions and private hospitals across India, Royal Sense Limited ensures the reliable supply of essential healthcare products. With a dedicated team of 8 professionals as of June 30, 2023, the company remains committed to delivering high-quality medical solutions nationwide.

Strengths

  • Expanding Digital Capabilities: Leveraging e-commerce and digital platforms for direct B2B and B2C sales, reducing dependency on traditional procurement models.
  • Product Innovation & R&D: Investing in research and partnerships to develop high-demand, high-margin healthcare products, such as telemedicine solutions or AI-driven diagnostics.
  • Regulatory & Compliance Strengthening: Ensuring robust compliance with healthcare regulations to maintain trust and eligibility for institutional contracts.
  • Strategic Market Expansion: Exploring untapped markets, both geographically and through product diversification, to reduce dependence on existing customer segments.

Risk factors

  • Supplier Diversification & Inventory Buffer: Establishing relationships with multiple suppliers and maintaining a strategic inventory reserve to minimize supply chain disruptions.
  • Government & Institutional Partnerships: Strengthening ties with healthcare institutions and government agencies to secure long-term contracts and reduce reliance on volatile customer orders.
  • Robust Financial & Credit Risk Management: Implementing strict credit control policies and diversifying revenue streams to manage uncertain customer payments.
  • Regulatory Compliance & Legal Readiness: Investing in a strong regulatory affairs team to ensure timely approvals and proactive compliance with evolving industry regulations.
  • Building Market Credibility: Leveraging case studies, partnerships, and financial transparency to mitigate concerns about its limited operating history and attract investor confidence.

Promoters

Mr. Rishabh Arora

Registrar & documents

Lead manager

Expert Global Consultants Private Limited

Registered office

First Floor, Plot No 57, Phase-II, Badli Industrial Area Badli, Delhi-110042

+91 9205843102

[email protected]Company website ↗

Frequently Asked Questions

What is Royal Sense IPO GMP today?

As of today, Royal Sense IPO Grey Market Premium (GMP) is reported at +₹37 per share. Based on the upper price band of ₹68, the estimated listing price is ₹105 (+54.4% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.

What is the lot size and minimum investment for Royal Sense IPO?

The minimum bid lot size for Royal Sense IPO is 2,000 shares. At the cut-off price of ₹68 per share, retail investors need a minimum application amount of ₹1,36,000 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).

When will Royal Sense IPO allotment status be announced?

The allotment status for Royal Sense IPO is scheduled to be finalized on 15 Mar 2024. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Bigshare Services Private Limited's official portal or via BSE/NSE allotment portals.

How can I check Royal Sense IPO allotment status online by PAN?

To check Royal Sense IPO allotment status: 1) Visit the registrar portal (Bigshare Services Private Limited) or the BSE IPO allotment page. 2) Select 'Royal Sense Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.